Responses to a Neutralizing Monoclonal Antibody for Hospitalized Patients With COVID-19 According to Baseline Antibody and Antigen Levels : A Randomized Controlled Trial. (2022)

First Author: ACTIV-3/TICO Bamlanivimab Study Group
Attributed to:  Respiratory infections funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.7326/m21-3507

PubMed Identifier: 34928698

Publication URI: http://europepmc.org/abstract/MED/34928698

Type: Journal Article/Review

Volume: 175

Parent Publication: Annals of internal medicine

Issue: 2

ISSN: 0003-4819